These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21167177)

  • 21. Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding.
    Xu S; Wu J; Sun B; Zhong C; Ding J
    Nucleic Acids Res; 2011 May; 39(10):4438-49. PubMed ID: 21266482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
    Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
    J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E. coli 5'-nucleotidase undergoes a hinge-bending domain rotation resembling a ball-and-socket motion.
    Knöfel T; Sträter N
    J Mol Biol; 2001 May; 309(1):255-66. PubMed ID: 11491294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMYD3-NY, a novel SMYD3 mRNA transcript variant, may have a role in human spermatogenesis.
    Zhou Z; Ren X; Huang X; Lu L; Xu M; Yin L; Li J; Sha J
    Ann Clin Lab Sci; 2005; 35(3):270-7. PubMed ID: 16081583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMYD proteins: key regulators in skeletal and cardiac muscle development and function.
    Du SJ; Tan X; Zhang J
    Anat Rec (Hoboken); 2014 Sep; 297(9):1650-62. PubMed ID: 25125178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the mechanism of domain closure and substrate specificity of glutamate dehydrogenase from Clostridium symbiosum.
    Stillman TJ; Migueis AM; Wang XG; Baker PJ; Britton KL; Engel PC; Rice DW
    J Mol Biol; 1999 Jan; 285(2):875-85. PubMed ID: 9878450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An archaeal SET domain protein exhibits distinct lysine methyltransferase activity towards DNA-associated protein MC1-alpha.
    Manzur KL; Zhou MM
    FEBS Lett; 2005 Jul; 579(17):3859-65. PubMed ID: 15978576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex.
    Lee JH; Maskos K; Huber R
    J Mol Biol; 2009 Aug; 391(4):744-57. PubMed ID: 19573535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducible covalent posttranslational modification of histone H3.
    Bode AM; Dong Z
    Sci STKE; 2005 Apr; 2005(281):re4. PubMed ID: 15855410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
    Luo XG; Zou JN; Wang SZ; Zhang TC; Xi T
    IUBMB Life; 2010 Mar; 62(3):194-9. PubMed ID: 20039369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The active site of the SET domain is constructed on a knot.
    Jacobs SA; Harp JM; Devarakonda S; Kim Y; Rastinejad F; Khorasanizadeh S
    Nat Struct Biol; 2002 Nov; 9(11):833-8. PubMed ID: 12389038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explaining the autoinhibition of the SMYD enzyme family: A theoretical study.
    Al-Shar'i NA; Alnabulsi SM
    J Mol Graph Model; 2016 Jul; 68():147-157. PubMed ID: 27447830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.
    Qian C; Wang X; Manzur K; Sachchidanand ; Farooq A; Zeng L; Wang R; Zhou MM
    J Mol Biol; 2006 May; 359(1):86-96. PubMed ID: 16603186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural snapshots of the KMSKS loop rearrangement for amino acid activation by bacterial tyrosyl-tRNA synthetase.
    Kobayashi T; Takimura T; Sekine R; Kelly VP; Kamata K; Sakamoto K; Nishimura S; Yokoyama S
    J Mol Biol; 2005 Feb; 346(1):105-17. PubMed ID: 15663931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
    Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
    Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone-modifying enzymes: encrypting an enigmatic epigenetic code.
    Couture JF; Trievel RC
    Curr Opin Struct Biol; 2006 Dec; 16(6):753-60. PubMed ID: 17070031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions.
    Yang X; Hu Y; Yin DH; Turner MA; Wang M; Borchardt RT; Howell PL; Kuczera K; Schowen RL
    Biochemistry; 2003 Feb; 42(7):1900-9. PubMed ID: 12590576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.